Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 20, 2026 17:28 ET | Source: BVI Medical, Inc.

AKTUALISIERUNG -- BVI gibt bekannt, dass Virtuoso®, eine neue chirurgische Plattform mit Doppelfunktion, die CE-Kennzeichnung gemäß EU-MDR erhalten hat

Die CE-Kennzeichnung gemäß der Medizinprodukteverordnung der Europäischen Union (EU-MDR) wurde für Virtuoso® erteilt, die erste Phako-Vitrektomie-Plattform mit Doppelfunktion von BVI, die für...
April 20, 2026 17:28 ET | Source: BVI Medical, Inc.

MISE À JOUR -- BVI annonce l’obtention du marquage CE au titre du Règlement européen sur les dispositifs médicaux pour Virtuoso®, une toute nouvelle plateforme chirurgicale à double fonction

Le marquage CE au titre du Règlement européen sur les dispositifs médicaux (MDR de l’UE) a été obtenu pour Virtuoso®, la première plateforme de phaco-vitrectomie à double fonction de BVI, conçue pour...
April 20, 2026 10:00 ET | Source: BVI Medical, Inc.

BVI Announces CE Mark Under EU MDR for Virtuoso®, A Brand New Dual-Function Surgical Platform

CE Mark under the European Union Medical Device Regulation (EU MDR) achieved for Virtuoso®, BVI’s first dual-function phaco-vitrectomy platform designed to deliver advanced control, efficiency, and...
April 20, 2026 09:46 ET | Source: BVI Medical, Inc.

HINWEIS ZUM NICHTBEACHTEN -- BVI Medical, Inc.

WALTHAM, Mass., April 20, 2026 (GLOBE NEWSWIRE) -- Wir wurden von BVI Medical, Inc. darauf hingewiesen, dass Journalisten und andere Leser die Pressemitteilung „BVI gibt bekannt, dass Virtuoso®,...
April 20, 2026 09:46 ET | Source: BVI Medical, Inc.

AVIS À IGNORER -- BVI Medical, Inc.

WALTHAM, Mass., 20 avr. 2026 (GLOBE NEWSWIRE) -- BVI Medical, Inc. nous informe que les journalistes et autres lecteurs doivent ignorer le communiqué de presse publié le 20 avril 2026, « BVI annonce...
January 19, 2026 09:00 ET | Source: BVI Medical, Inc.

BVI Appoints Jim Hollingshead as President & Chief Executive Officer

BVI appoints Jim Hollingshead as President & CEO, succeeding Shervin Korangy, to lead the company’s next phase of global growth and innovation.
October 14, 2025 07:34 ET | Source: BVI Medical, Inc.

BVI’s FINEVISION® HP Gains FDA Approval, Ushering in a New Era of Advanced Trifocal IOLs for U.S. Patients

BVI has received FDA approval for its FineVision HP® trifocal intraocular lens (IOL), a major milestone in advanced cataract surgery for U.S. patients.
September 03, 2025 10:00 ET | Source: BVI Medical, Inc.

BVI Unveils Virtuoso® – A Novel Dual-Function Surgical Platform for Cataract and Vitreoretinal Procedures

BVI launches Virtuoso®, a dual-function phaco-vitrectomy system debuting at Euretina & ESCRS 2025, uniting cataract and retinal surgery.
April 17, 2025 11:00 ET | Source: BVI Medical, Inc.

BVI Medical Announces Approval of Breakthrough Technology: FDA 510(k) Clearance of its Laser Endoscopy Ophthalmic System: Leos™

BVI Medical, announced that it has received 510(k) clearance from the U.S. FDA for its innovative glaucoma surgical system, Leos™
April 17, 2024 22:00 ET | Source: BVI Medical, Inc.

BVI Launches PODEYE Hydrophobic Monofocal IOL in Japan

Second BVI Market Debut in Less Than Twelve Months BVI continues to execute its roadmap of IOL launches in Japan, the world's third-largest IOL-valued market1The PODEYE hydrophobic monofocal is...